Veracyte (VCYT) News Today $36.02 +0.03 (+0.07%) As of 11:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VCYT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Veracyte (VCYT): Reassessing Valuation After New BALANCE Trial Data Highlights Decipher’s Clinical Impact2 hours ago | finance.yahoo.comWilliam Blair Reaffirms Their Buy Rating on Veracyte (VCYT)October 4 at 9:40 AM | theglobeandmail.comBrokerages Set Veracyte, Inc. (NASDAQ:VCYT) Price Target at $40.90October 4 at 2:23 AM | americanbankingnews.comAMI Asset Management Corp Sells 8,580 Shares of Veracyte, Inc. $VCYTOctober 2, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by AnalystsOctober 1, 2025 | marketbeat.comVeracyte announces results from BALANCE trial of PAM50September 29, 2025 | msn.comVeracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate CancerSeptember 28, 2025 | businesswire.comVeracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025September 24, 2025 | finance.yahoo.comAnnie Mcguire Sells 2,283 Shares of Veracyte (NASDAQ:VCYT) StockSeptember 24, 2025 | insidertrades.comVoya Investment Management LLC Increases Stock Holdings in Veracyte, Inc. $VCYTSeptember 24, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) SVP Annie Mcguire Sells 2,283 SharesSeptember 23, 2025 | marketbeat.comAssenagon Asset Management S.A. Raises Stock Holdings in Veracyte, Inc. $VCYTSeptember 22, 2025 | marketbeat.comExchange Traded Concepts LLC Purchases 23,047 Shares of Veracyte, Inc. $VCYTSeptember 21, 2025 | marketbeat.comStrs Ohio Takes Position in Veracyte, Inc. $VCYTSeptember 20, 2025 | marketbeat.comAQR Capital Management LLC Lowers Stock Position in Veracyte, Inc. $VCYTSeptember 15, 2025 | marketbeat.comVeracyte, Inc. $VCYT Stake Trimmed by Great Lakes Advisors LLCSeptember 13, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) CEO Sells 7,667 SharesSeptember 10, 2025 | marketbeat.comVeracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual MeetingSeptember 10, 2025 | finance.yahoo.comVeracyte, Inc. (VCYT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comMarc Stapley Sells 7,667 Shares of Veracyte (NASDAQ:VCYT) StockSeptember 9, 2025 | insidertrades.comVeracyte, Inc. $VCYT Stake Lifted by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comBridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYTSeptember 8, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of "Moderate Buy" from AnalystsSeptember 8, 2025 | marketbeat.comRaymond James Financial Inc. Purchases 172,010 Shares of Veracyte, Inc. $VCYTSeptember 6, 2025 | marketbeat.comPDT Partners LLC Sells 27,566 Shares of Veracyte, Inc. $VCYTSeptember 5, 2025 | marketbeat.comMagnetar Financial LLC Invests $651,000 in Veracyte, Inc. $VCYTSeptember 3, 2025 | marketbeat.comTrexquant Investment LP Sells 10,790 Shares of Veracyte, Inc. $VCYTSeptember 3, 2025 | marketbeat.comHsbc Holdings PLC Buys 10,618 Shares of Veracyte, Inc. $VCYTSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Has $3.29 Million Stock Position in Veracyte, Inc. $VCYTSeptember 1, 2025 | marketbeat.comNorthern Trust Corp Trims Stake in Veracyte, Inc. $VCYTSeptember 1, 2025 | marketbeat.comDriehaus Capital Management LLC Purchases 167,604 Shares of Veracyte, Inc. $VCYTAugust 31, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 28,644 Shares of Veracyte, Inc. $VCYTAugust 31, 2025 | marketbeat.comNext Century Growth Investors LLC Lowers Stake in Veracyte, Inc. $VCYTAugust 30, 2025 | marketbeat.comVeracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare ConferenceAugust 29, 2025 | businesswire.comVeracyte reports Phase 3 STAMPEDE trial finding published in CellAugust 28, 2025 | msn.comVeracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate CancerAugust 27, 2025 | businesswire.comVirtus Advisers LLC Acquires Shares of 36,230 Veracyte, Inc. $VCYTAugust 27, 2025 | marketbeat.com76,342 Shares in Veracyte, Inc. $VCYT Acquired by Campbell & CO Investment Adviser LLCAugust 27, 2025 | marketbeat.comInvesco Ltd. Lowers Position in Veracyte, Inc. $VCYTAugust 27, 2025 | marketbeat.comVeracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer TestAugust 26, 2025 | finance.yahoo.comVeracyte: Q2 Earnings Brings My Position Out Of MothballsAugust 26, 2025 | seekingalpha.comHow Investors May Respond To Veracyte (VCYT) Earnings Upgrades and Spotlight as a Momentum StockAugust 24, 2025 | finance.yahoo.comAdvantage Alpha Capital Partners LP Has $779,000 Stake in Veracyte, Inc. $VCYTAugust 24, 2025 | marketbeat.comWellington Management Group LLP Has $114.25 Million Stake in Veracyte, Inc. $VCYTAugust 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $21.96 Million Stake in Veracyte, Inc. $VCYTAugust 24, 2025 | marketbeat.comCraig-Hallum Sticks to Its Buy Rating for Veracyte (VCYT)August 23, 2025 | theglobeandmail.comCraig-Hallum Remains a Buy on Veracyte (VCYT)August 23, 2025 | theglobeandmail.comDeutsche Bank AG Sells 9,272 Shares of Veracyte, Inc. $VCYTAugust 23, 2025 | marketbeat.com15,400 Shares in Veracyte, Inc. $VCYT Acquired by Northwest & Ethical Investments L.P.August 22, 2025 | marketbeat.comEverSource Wealth Advisors LLC Acquires 15,832 Shares of Veracyte, Inc. $VCYTAugust 20, 2025 | marketbeat.com Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼0.600.54▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼48▲VCYT Articles Average Week Get the Latest News and Ratings for VCYT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Veracyte and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Adaptive Biotechnologies News Today Beam Therapeutics News Today Guardant Health News Today Twist Bioscience News Today 10x Genomics News Today RadNet News Today BrightSpring Health Services News Today Sotera Health News Today Option Care Health News Today GeneDx News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthGovernment Gridlock – The Final Act in a Collapse Trump's extension of this wealth saving loophole may be y...American Hartford Gold | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
